Skin Graft Market to Grow at a CAGR of 7.0% to reach US$ 1,673.5 million from 2020 to 2028

Skin Graft Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics) and Geography

Publication Month: Apr 2021 | Report Code: TIPHE100001099 | No. of Pages: No. of Pages203 | Category: Medical Device | Status: Published

The skin graft market was valued at US$ 985.4 million in 2020 and is projected to reach US$ 1,673.5 million by 2028; it is expected to grow at a CAGR of 7.0% from 2021 to 2028.

Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. In Skin skin grafting procedure,  isa small patch of the skin, which is  is removed from a patient’s body part and attached to or transplanted to the affected area of the bodyremoved from skin of the other part of the patient’s body by a surgery. The patch of skin is transplanted or attached to the injured sit or the burnt site.
The skin graft market is segmented on the basis of product, graft thickness, application, equipment, end-users, and region. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the skin graft market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID–19 pandemic on the market across all the regions. Due to the outbreak of COVID-19 outbreak, various hospitals were are engaged in treating the affected infected people. AdditionallyAs,  various wound care centers are located inoperate from hospitals. , Hence, majority of the patients did notare unable to receive the wound care treatment. ~ Approximately 1 in 4 patients is able to receives wound care treatment, and it is expected that there are nearly 6.7 million people across the US those are waiting for the wound treatment. Researchers evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces, and the dermal disinfection effectiveness of 80 per cent (w/w) ethanol against SARS-CoV-2 and IAV. To avoid infecting healthy volunteers, researchers conducted lab experiments using cadaver skin that would have otherwise been used for skin grafts. The outbreak of COVID-19 outbreak has negatively impacted the skin graft market profoundly by affecting the quality care.

Lucrative Regions for Skin graft Graft Market      

Lucrative Regions for Skin graft Graft Market

Get more information on this report :

Market Insights

Rising Prevalence of Skin Cancer and Diabetes

Skin grafts are ideally preferred post-surgery for skin cancers. Skin grafts are generally referred for local postoperative radiotherapy (PORT) to ensure closure of surgical bed created during radiotherapy. According to Cancer Research UK, ~15,400 new melanoma skin cancer cases are registered in the UK every year, accounting for 42 new cases every day. Incidence rates for melanoma skin cancer are projected to rise by 7% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035. Likewise, according to the recent statistics published by the International Agency for Research on Cancer, in 2020, 19.3 million new cancer cases were registered, excluding 18.1 million for nonmelanoma skin cancer. Thus, an increase in the prevalence of skin cancer is likely to contribute to skin grafting in the coming future.

Diabetes is among the most common health conditions prevalent across the globe. According to the International Diabetes Federation’s (IDF) IDF Diabetes Atlas Ninth edition 2019, ~463 million adults were living with diabetes worldwide. The prevalence is estimated to be 700 million by 2045—nearly 79% of adults living with diabetes in low-and-middle incomes countries worldwide. Among the prevalence of diabetes, the proportion of type 2 diabetes is increasing at a much faster rate. According to the IDF, 374 million are at risk of developing type 2 diabetes in the coming future. Among diabetic patients, wound healing is prolonged, which increases the risk of skin infections if it is not healed within a particular time. ~25% of diabetic patients are likely to develop foot ulcers once in their lifetime that often need advanced diabetic wound care. Therefore, there is an increase in demand for skin grafts to treat or cover diabetic foot ulcers by eliminating the chances of contracting skin infections. Thus, the high prevalence rate of skin cancer and diabetes is expected to drive skin graft market in the near future.

Product -Based Insights

Based on type, the skin graft market is segmented segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. The autologous segment accounted forheld the global pharmaceutical intermediate market'sthe largestst market share in 2020, and the market for the same segment market is anticipated to grow faster at the highest rate during 2021–2028. The market growth for autologous segment can be attributed to the wide use of autologous grafts are used widely for treating open burns and wounds.

                                                                            Global Skin graft Graft Market, by Product– 2020 & 2028

Get more information on this report :

Application-Based Insights

Based on application, the skin graft market is segmented into burns, extensive wound, skin cancer, and other applications. The burns segment held the largest share of the market in 2020. and The same segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report CoverageDetails
Market Size Value inUS$ 985.4 Million in 2020
Market Size Value byUS$ 1,673.5 Million by 2028
Growth rateCAGR of 7.0% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages203
No. of Tables138
No. of Charts & Figures84
Historical data availableYes
Segments coveredProduct , Graft Thickness , Application , Equipment , and End User and Geography
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater tomeet changing customer demand and maintain their brand name across the world. Market players operating in the skin graft market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

By Product

  • Autologous
  • Allogeneic
  • Xenogeneic
  • Prosthetic
  • Isogeneic

By Graft Thickness                          

  • Split-Thickness
  • Full-Thickness
  • Composite Graft

By Application                                 

  • Burns
  • Extensive Wound
  • Skin Cancer
  • Other Applications

By Equipment                                 

  • Dermatome
  • General Surgical Instruments
  • Consumables
  • Others Market

By End Users                                  

  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatology Clinics

By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • B. Braun Melsungen AG
  • Integra Life Sciences Corporation
  • Smith & Nephew
  • AVITA Medical
  • MiMedx
  • Organogenesis Inc
  • Tissue Regenix Group
  • Zimmer Biomet
  • De Soutter Medical
  • Nouvag AG

Frequently Asked Questions

Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. Skin graft is small patch of skin, which is removed from skin of the other part of the patient’s body by a surgery. The patch of skin is transplanted or attached to the injured sit or the burnt site.
The growth of the market is attributed to Increasing numbers of burn injuries, and rising prevalence of skin cancer and diabetes. However, high cost of skin grafting procedures and alternatives for skin grafts hinders the market growth.
The types of pharmacy automation equipment are autologous, allogeneic, xenogeneic, prosthetic, and isogeneic.

The List of Companies - Skin Graft Market

  1. B. Braun Melsungen AG
  2. Integra Life Sciences Corporation
  3. Smith & Nephew
  4. AVITA Medical
  5. MiMedx
  6. Organogenesis Inc
  7. Tissue Regenix Group
  8. Zimmer Biomet
  9. De Soutter Medical
  10. Nouvag AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the skin graft market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global skin graft market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount